Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population.
Wendy Y ChengSujata P SardaNikita Mody-PatelSangeeta KrishnanMihran YenikomshianColin KunzweilerJensen Duy VuHoi Ching CheungMei Sheng DuhPublished in: ClinicoEconomics and outcomes research : CEOR (2022)
Results suggest that deviations from label-recommended dosing patterns were common. Future budget impact assessments of eculizumab should account for real-world dosing patterns to comprehensively assess costs and benefits.